Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ZF2001 Potential treatment - clinical evidence Experimental Vaccine Mar/24/2021 1 0
TRS-2 PPMO Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020 1 0
TRS-1 PPMO Potential treatment - pre-clinical evidence Experimental Antiviral Nov/09/2020 1 0
Trefoil factor 2 Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/20/2020 2 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 10 2
Tixagevimab Emergency use authorization Experimental Antiviral Jan/26/2022 8 3
Sotrovimab Emergency use authorization Experimental Antiviral Dec/23/2021 4 1
SΔC-Fer Potential treatment - pre-clinical evidence Experimental Vaccine Jan/05/2021 1 0
scFv-IL6R-Fc Potential treatment - theoretical effect Experimental Other treatment Jun/11/2021 1 0
SARS-CoV-2 RBD-Fc Potential treatment - pre-clinical evidence Experimental Vaccine Nov/27/2020 1 0